Check this out: That’s the chart for a company called Macrogenix (MGNX). It’s a trashy little biotech stock you’ve probably never heard of before. They’re developing ways to use monoclonal antibodies to fight tumors. From the June lows the stock is up over 150%. Then came the earnings call a few days ago and… lo […]